Enhanced Plasminogen Activator Inhibitor-1 Expression in Transgenic Mice with Hepatocyte-Specific Overexpression of Superoxide Dismutase or Glutathione Peroxidase
Authors:
- Katja CurthKCKatja Curth
- Jacek LenartJLJacek Lenart
- Doreen KnochenhauerDKDoreen Knochenhauer
- Thomas KietzmannThomas Kietzmann
- 1 August 2004
- journal article
- research article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 6 (4) , 721-728
Abstract
In this study, we developed a double-transgenic mouse model allowing hepatocyte-specific and regulated expression of the redox-modifying enzymes copper/zinc superoxide dismutase (SOD) and glutathione peroxidase (GPX) by using a tetracycline-regulatable gene expression system. Within this system, the SOD and GPX level can be regulated deliberately by addition or removal of doxycycline hydrochloride to the drinking water. As reactive oxygen species (ROS) have been implicated in a number of pathological conditions, such as atherosclerosis, thrombosis, or liver fibrosis, processes that are also frequently associated with enhanced levels of plasminogen activator inhibitor-1 (PAI-1), it was the aim of the present study to investigate the influence of SOD and GPX overexpression on the regulation of PAI-1. PAI-1 mRNA and protein levels in tetracycline transactivator-dependent SOD-overexpressing double-transgenic mice reached values 2.5- to threefold above the normal mRNA level. By applying doxycycline, a deinduction of the PAI-1 levels was observed. By using the same protocol, PAI-1 mRNA and protein levels were enhanced in GPX double-transgenic mice, and again this response was blunted by the addition of doxycycline. These studies provide some new informaton regarding the role of ROS within the proteolytic processes in hepatocytes that require PAI-1.Keywords
This publication has 46 references indexed in Scilit:
- Reactive oxygen species mediate TGF-β1-induced plasminogen activator inhibitor-1 upregulation in mesangial cellsBiochemical and Biophysical Research Communications, 2003
- Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-κB and free radical in proximal tubular cellsKidney International, 2003
- Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: Impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosisHepatology, 2001
- Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.Journal of Clinical Investigation, 1998
- Induction of Tissue-Type Plasminogen Activator (tPA) and Type-1 Plasminogen Activator Inhibitor (PAI-1) as Early Growth Responses in Rat Hepatocytes in Primary CultureBiochemical and Biophysical Research Communications, 1997
- Cyclic Strain-Induced Plasminogen Activator Inhibitor-1 (PAI-1) Release from Endothelial Cells Involves Reactive Oxygen SpeciesBiochemical and Biophysical Research Communications, 1996
- Regulation of the gluconeogenic phosphoenolpyruvate carboxykinase and the glycolytic aldolase A gene expression by O2 in rat hepatocyte cultures. Involvement of hydrogen peroxide as mediator in the response to O2FEBS Letters, 1996
- IV liver cancerHepatology, 1995
- The defence against free radicals protects endothelial cells from hyperglycaemia-induced plasminogen activator inhibitor 1 over-productionBlood Coagulation & Fibrinolysis, 1995
- Predominant localization of phosphoenolpyruvate carboxykinase mRNA in the periportal zone of rat liver parenchyma demonstrated by in situ hybridizationFEBS Letters, 1989